Trial intelligence / Profile preview

Dexmedetomidine in suprazygomatic maxillary nerve block for cleft palate surgery

PACTR201703002080167Completed

Sponsor
Faculty of Medicine, Tanta University
Start
May 2016
Modality
Small Molecules
Countries
1
01

Overview

Trial of dexmedetomidine and bupivacaine in cleft palate (2 arms), sponsored by Faculty of Medicine, Tanta University. Primary endpoint: Postoperative pain. Started May 2016; status: completed.

02

Drugs

dexmedetomidinebupivacaine
03

Conditions

cleft palate

Beyond the preview

Go deeper on PACTR201703002080167.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201703002080167.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call